Results 1 to 10 of about 3,002 (184)

Deficiência da glicose-6-fosfato desidrogenase com infecções de repetição: relato de caso Glucose-6-phosphate dehydrogenase deficiency with recurrent infections: case report [PDF]

open access: yesJornal de Pediatria, 2001
OBJETIVO: relatar a ocorrência de uma deficiência funcional de neutrófilos rara, com quadro clínico e laboratorial semelhante ao da doença granulomatosa crônica.
Abertina Rosa-Borges   +9 more
doaj   +4 more sources

Pediatric Mixed Plasmodium vivaxP. falciparum Infection with Disparate Parasitemias: Diagnostic and Surveillance Challenges [PDF]

open access: yesChildren
Background and Clinical Significance: Malaria remains a significant public health issue in Latin America, where Plasmodium vivax predominates but P. falciparum continues to circulate.
Jose Luis Estela-Zape
doaj   +2 more sources

Molecular Characterization of Glucose-6-phosphate Dehydrogenase Deficiency in Oman

open access: yesOman Medical Journal, 2023
Objectives: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most encountered abnormality of red blood cell metabolism worldwide and has a high prevalence in Oman.
Ammar Al-Sheryani1,   +5 more
doaj   +1 more source

Dental Management of a Patient with Pulmonary Atresia and Ventricular Septal Defect

open access: yesFrontiers in Dentistry, 2021
Pulmonary atresia with ventricular septal defect (PA/VSD) is one of the congenital heart diseases that results in cyanosis, susceptibility to bacterial endocarditis, and increased risk of complications during general anesthesia.
Ghassem Ansari   +2 more
doaj   +1 more source

Population screening for glucose-6-phosphate dehydrogenase deficiency using quantitative point-of-care tests: a systematic review

open access: yesFrontiers in Genetics, 2023
Background: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an X-linked hereditary disorder and a global public health concern that is most prevalent in malaria-endemic regions including Asia, Africa, and the Mediterranean.
Mohamed Afiq Hidayat Zailani   +6 more
doaj   +1 more source

Glucose-6-phosphate Dehydrogenase Deficiency: A Review

open access: yesInternational Journal of Medical Students, 2020
Deficiency of glucose-6-phosphate dehydrogenase enzyme is a common X-linked disorder that affects humans globally. It was first identified in the 1950s as a disorder that primarily affects the red blood cells causing a myriad of symptoms including acute
Nidhruv Ravikumar, Graeme Greenfield
doaj   +1 more source

Neonatal indirect hyperbilirubinemia and glucose-6-phosphate dehydrogenase deficiency [PDF]

open access: yesKorean Journal of Pediatrics, 2017
PurposeThis study aimed to determine the prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency among infants with neonatal indirect hyperbilirubinemia (NIH); compare G6PD-deficient and G6PD-normal patients regarding hyperbilirubinemia and ...
Hasan M. Isa   +4 more
doaj   +1 more source

Confounding factors in the diagnosis and clinical course of rare congenital hemolytic anemias

open access: yesOrphanet Journal of Rare Diseases, 2021
Congenital hemolytic anemias (CHAs) comprise defects of the erythrocyte membrane proteins and of red blood cell enzymes metabolism, along with alterations of erythropoiesis.
Bruno Fattizzo   +3 more
doaj   +1 more source

Prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency in southeast Iran: implications for malaria elimination

open access: yesJournal of Infection in Developing Countries, 2015
Introduction: Glucose-6-phosphate dehydrogenase deficiency (G6PD) is an X-linked genetic disorder with a relatively high frequency in malaria-endemic regions.
Seyed Mehdi Tabatabaei   +4 more
doaj   +1 more source

Prevalência da deficiência da glicose-6-fosfato desidrogenase em doadores de sangue de Mossoró, Rio Grande do Norte Prevalence of glucose-6-phosphate dehydrogenase deficiency in blood donors of Mossoró, Rio Grande do Norte

open access: yesRevista Brasileira de Hematologia e Hemoterapia, 2010
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common human enzymopathy. It affects as many as 330 million individuals worldwide.
Ulysses Madureira Maia   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy